Translational Science by Manish Singhal
Session 2 : Translational Science
Chairpersons :
Ramesh Nimmagadda, R K Deshpande
Speaker :
Manish Singhal
Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer: A randomized, phase 2 study
Author: Han HS
Conference: 2016 SABCS S2-05
DNA repair deficiency biomarkers and MammaPrint high1/(ultra) high 2 risk as predictors of veliparib / carboplatin response: Results from the neoadjuvant I-SPY 2 trial for high risk breast cancer
Author: Wolf DM
Conference: 2016 SABCS S2-06
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
Author: HS Rugo
Reference: N. Engl. J. Med; 2016 Jul 7; 375(1)23-34